Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.

Factors Influencing Infarct Size Following Experimental Coronary Artery Occlusions

1971 • 1,500 citations

Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy

1983 • 684 citations

Rate of Calcium Binding and Uptake in Normal Animal and Failing Human Cardiac Muscle: MEMBRANE VESICLES (RELAXING SYSTEM) AND MITOCHONDRIA

1969 • 521 citations

Prostaglandins in Severe Congestive Heart Failure

1984 • 434 citations

Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.

1978 • 426 citations

PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADE

1979 • 415 citations

Prognosis in severe heart failure: Relation to hemodynamic measurements and ventricular ectopic activity

1983 • 395 citations

Hemodynamic Assessment of Amrinone

1978 • 390 citations

Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.

1983 • 234 citations

Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man.

1979 • 215 citations

The Role of Free Fatty Acids in the Production of Ventricular Arrhythmias after Acute Coronary Artery Occlusion

1971 • 192 citations

Nitrate Therapy for Congestive Heart Failure

1978 • 173 citations

The Arrhythmogenic Effects of Caffeine in Human Beings

1983 • 165 citations

Biochemical Studies on the Mechanism of Cardiotonic Activity of MDL 17,043

1982 • 152 citations

Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.

1983 • 147 citations

The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.

1983 • 135 citations

Vasodilator and inotropic therapy for severe chronic heart failure: Passion and skepticism

1983 • 130 citations

Correction of Dilutional Hyponatremia in Severe Chronic Heart Failure by Converting-Enzyme Inhibition

1984 • 124 citations

Rebound Hemodynamic Events after the Abrupt Withdrawal of Nitroprusside in Patients with Severe Chronic Heart Failure

1979 • 122 citations

Excitation-contraction coupling in heart

1971 • 120 citations

Intracellular Calcium and Myocardial Contractility

1970 • 113 citations

Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure

1980 • 106 citations

Amrinone and exercise performance in patients with chronic heart failure

1981 • 103 citations

Hemodynamic Characterization of Tolerance to Long-Term Hydralazine Therapy in Severe Chronic Heart Failure

1982 • 101 citations

Haemodynamic effects of intravenous amrinone in patients with impaired left ventricular function.

1983 • 94 citations

Long-term amrinone therapy in patients with severe heart failure

1982 • 90 citations

Long-term therapy with a new cardiotonic agent, WIN 47203: Drug-dependent improvement in cardiac performance and progression of the underlying disease

1983 • 83 citations

Side effects of amrinone therapy.

1983 • 81 citations

Beneficial effect of amrinone on myocardial oxygen consumption during acute left ventricular failure in dogs

1981 • 69 citations

Physiologic and pharmacologic determinants of vasodilator response: A conceptual framework for rational drug therapy for chronic heart failure

1982 • 67 citations

Amrinone therapy for congestive heart failure in outpatients with idiopathic dilated cardiomyopathy

1983 • 59 citations

Mechanisms of beneficial effects of vasodilators and inotropic stimulation in the experimental failing ischemic heart

1978 • 57 citations

Hemodynamic effects of intravenous prenalterol in severe heart failure

1981 • 55 citations

Amrinone in the treatment of chronic cardiac failure

1984 • 52 citations

Direct vasodilator and positive inotropic actions of amrinone

1980 • 51 citations

The role of cyclic AMP in isoprenaline-induced cardiac necroses in the rat

1971 • 44 citations

Effects of amrinone on experimental acute myocardial ischaemic injury

1980 • 37 citations

Effects of amrinone, a cardiotonic drug, on calcium movements in dog erythrocytes.

1980 • 37 citations

Acute and chronic effects of pirbuterol on left ventricular ejection fraction and clinical status in severe congestive heart failure

1981 • 27 citations

Pharmacological actions of various inotropic agents

1983 • 26 citations

Clinical Experience with Amrinone in Patients with Advanced Congestive Heart Failure

1982 • 25 citations

New hope for the failing heart

1982 • 22 citations

Myocardial degeneration in mice treated with dibutyryl cyclic AMP and/or theophylline

1976 • 19 citations

Plasma cyclic adenosine 3′5′-monophosphate (AMP) levels in acute myocardial infarction

1974 • 16 citations